Response Biomedical Restates Earnings Results After Ongoing Internal Review | GenomeWeb

By a GenomeWeb staff reporter



NEW YORK (GenomeWeb News) – Response Biomedical today said that it is restating and refiling numerous financial results, following an ongoing internal review and consultation with its external auditors.

The changes affect previously disclosed earnings results for full-year 2010 as well as the first half of 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.